Treating pediatric ALL with chimeric antigen receptor (CAR) T-cell therapy
New monoclonal antibodies for ALL treatment
Commercialising leukemia and lymphoma therapies - future challenges
Can we work together on a global scale to defeat AML?
Safety issues with CAR T-cell therapy for acute lymphocytic leukemia